Publication | Open Access
Atypical BCR-ABL mRNA transcripts in adult Acute lymphoblastic leukemia
44
Citations
16
References
2007
Year
Hematological MalignancyTumor BiologyOncologyMedicineMixed-phenotype Acute LeukemiaHematologyBcr GenePathologyImmunologyGmall Study GroupBcr-abl-positive CasesAdult T-cell Leukemia-lymphomaGene ExpressionMolecular DiagnosticsCell BiologyCancer ResearchMolecular OncologyMinor Breakpoint Transcripts
RT‑PCR detects chimeric BCR‑ABL mRNA in about 25 % of adult ALL cases, with minor breakpoint transcripts (e1a2) in ~70 % and major transcripts (e13a2/e14a2) in ~30 %, but atypical transcripts are occasionally seen. We identified eight adult ALL cases with atypical BCR‑ABL transcripts (5 e1a3, 2 e13a3, 1 e6a2) using data from the GMALL Study Group. These atypical transcripts occur in about 1–2 % of all BCR‑ABL‑positive adult ALL cases, and their clinical courses were described with diagnostic proposals.
RT-PCR detects chimeric BCR-ABL mRNA in approximately 25% of adult acute lymphoblastic leukemia (ALL) cases. Minor breakpoint transcripts (e1a2) are found in about 70% of positive cases and major breakpoint transcripts (e13a2, e14a2) in about 30% of cases. However, other atypical transcripts are sometimes observed. We report experience gained in the GMALL Study Group and identified 8 BCR-ABL-positive adult ALL cases with such atypical transcripts: 5 with e1a3, 2 with e13a3 (b2a3), and 1 with e6a2. This corresponds to a prevalence of 1-2% of all BCR-ABL-positive cases. The clinical courses are reported and diagnostic proposals are made.
| Year | Citations | |
|---|---|---|
Page 1
Page 1